glp-1 weight loss per month The Access Gap: Mapping Who Can Actually Afford America's Miracle Weight-Loss Drugs GLP-1 Survey: 37.5% of People
Description
The use of GLP-1 RA was associated with a higher incidence of thyroid cancer (TC), specifically medullary TC, after one to three years of treatment, according to Bezin et al

It helps users consume less and burn more, including subcutaneous fat

Built-in telehealth infrastructure: No need for separate platform subscriptions (Zoom, Doxy, etc.)

NDTV reported that Sun Pharma launched Noveltreat for chronic weight management and Sematrinity for type 2 diabetes

A generic for dulaglutide (Trulicity) could be available at the end of 2027

Published: Mar 8, 2026 Written by Klarity Editorial Team Published: Mar 8, 2026 Youve probably noticed it: patients asking about Ozempic at the end of sessions
